Bydd pobl â chlefyd Parkinson yng Nghymru bellach yn gallu cael y cyffur Opicapone yn haws.
People with Parkinson's in Wales will now be able to access the drug Opicapone more easily.
Research shows that deep brain stimulation may help boost energy levels in Parkinson’s brain cells by increasing the size of mitochondria.
A potential drug for dyskinesia has reached an important milestone and can now go forward into clinical trials.
Parkinson's UK has teamed up with Sport England to deliver an innovative project that will help inactive people with Parkinson's become and stay physically active.
An update on a parliamentary event to highlight the social care needs of working-age people with Parkinson's and other long term conditions.
The pioneering GDNF clinical trials programme delivered an experimental treatment directly to the brain. The trial results offer hope that it may be possible to restore the cells damaged in Parkinson’s.
We update on the latest government announcement on the prescription charge rise and our campaigning.
Parkinson's UK is 1 of 24 members of the Association of Medical Research Charities that have worked in collaboration to develop and launch a new open publication platform – AMRC Open Research.
We gave oral evidence to the Work and Pensions Committee on their inquiry into the welfare safety net.
Researchers at King’s College London are starting a world-first clinical trial to test if a probiotic drink could help with motor and non-motor symptoms of Parkinson's.